HEADER VIRAL PROTEIN 13-JUN-22 8A4Y TITLE SARS-COV-2 NON-STRUCTURAL PROTEIN-1 (NSP1) IN COMPLEX WITH N-(2,3- TITLE 2 DIHYDRO-1H-INDEN-5-YL)ACETAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HOST TRANSLATION INHIBITOR NSP1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LEADER PROTEIN,NON-STRUCTURAL PROTEIN 1,NSP1,SARS-COV-2 NON- COMPND 5 STRUCTURAL PROTEIN 1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SARS-COV-2, NON-STRUCTURAL PROTEIN-1, FRAGMENT HIT, COMPLEX, VIRAL KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.BORSATTO,I.GALDADAS,S.MA,S.DAMFO,S.HAIDER,F.KOZIELSKI,C.ESTARELLAS, AUTHOR 2 F.L.GERVASIO REVDAT 3 31-JAN-24 8A4Y 1 REMARK REVDAT 2 30-NOV-22 8A4Y 1 JRNL REVDAT 1 23-NOV-22 8A4Y 0 JRNL AUTH A.BORSATTO,O.AKKAD,I.GALDADAS,S.MA,S.DAMFO,S.HAIDER, JRNL AUTH 2 F.KOZIELSKI,C.ESTARELLAS,F.L.GERVASIO JRNL TITL REVEALING DRUGGABLE CRYPTIC POCKETS IN THE NSP1 OF JRNL TITL 2 SARS-COV-2 AND OTHER BETA-CORONAVIRUSES BY SIMULATIONS AND JRNL TITL 3 CRYSTALLOGRAPHY. JRNL REF ELIFE V. 11 2022 JRNL REFN ESSN 2050-084X JRNL PMID 36412088 JRNL DOI 10.7554/ELIFE.81167 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4092 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 40438 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.148 REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.166 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2064 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.5050 - 2.7093 1.00 2863 124 0.1553 0.1680 REMARK 3 2 2.7093 - 2.1505 1.00 2637 138 0.1578 0.1663 REMARK 3 3 2.1505 - 1.8787 1.00 2600 156 0.1327 0.1648 REMARK 3 4 1.8787 - 1.7069 1.00 2585 125 0.1383 0.1572 REMARK 3 5 1.7069 - 1.5846 1.00 2548 149 0.1264 0.1479 REMARK 3 6 1.5846 - 1.4911 1.00 2563 133 0.1194 0.1639 REMARK 3 7 1.4911 - 1.4165 1.00 2525 141 0.1220 0.1481 REMARK 3 8 1.4165 - 1.3548 1.00 2534 136 0.1336 0.1689 REMARK 3 9 1.3548 - 1.3026 1.00 2506 133 0.1341 0.1595 REMARK 3 10 1.3026 - 1.2577 1.00 2507 163 0.1471 0.1803 REMARK 3 11 1.2577 - 1.2184 1.00 2531 126 0.1485 0.1852 REMARK 3 12 1.2184 - 1.1835 1.00 2454 144 0.1602 0.1749 REMARK 3 13 1.1835 - 1.1524 1.00 2530 148 0.1556 0.1684 REMARK 3 14 1.1524 - 1.1243 1.00 2508 117 0.1664 0.2070 REMARK 3 15 1.1243 - 1.0990 0.98 2483 131 0.2073 0.2219 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.080 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.070 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 966 REMARK 3 ANGLE : 1.270 1320 REMARK 3 CHIRALITY : 0.093 156 REMARK 3 PLANARITY : 0.008 171 REMARK 3 DIHEDRAL : 18.113 367 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8A4Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292123640. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96546 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC V1.0 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC V1.0 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40443 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.099 REMARK 200 RESOLUTION RANGE LOW (A) : 35.505 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 11.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.19_4092 REMARK 200 STARTING MODEL: 7K7P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 32.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: COMMERCIAL SCREEN INDEX 44 (0.1 M REMARK 280 HEPES PH 7.5, 25% W/V PEG3350) WAS CHOSEN FOR SARS-COV-2 NSP1 REMARK 280 (RESIDUES 10 TO 126) CRYSTALLISATION IN LARGE QUANTITIES USING REMARK 280 HANGING DROP METHOD. FROZEN STOCKS OF SARS-COV-2 NSP1 (RESIDUES REMARK 280 10 TO 126) WERE THAWED ON ICE AND CENTRIFUGED IN A THERMO REMARK 280 SCIENTIFIC PICO 17 MICROCENTRIFUGE, 24-PL ROTOR AT 4 DEGREES, REMARK 280 20000 RPM FOR 10 MIN TO REMOVE AGGREGATES BEFORE THE REMARK 280 DETERMINATION OF THE PROTEIN CONCENTRATION. SUBSEQUENTLY, THE REMARK 280 PROTEIN STOCK WAS DILUTED TO 20 MG/ML WITH PRECRYSTALLISATION REMARK 280 BUFFER (10 MM HEPES AND 300 MM NACL). 400 UL OF INDEX CONDITION REMARK 280 44 WAS ADDED INTO EACH RESERVOIR WELL. FIVE PROTEIN DROPS WERE REMARK 280 SET ON EACH COVER SLIP BY MIXING 1 UL OF PROTEIN SOLUTION WITH 1 REMARK 280 UL OF THE RESERVOIR. THE 24-WELL LINBRO PLATES WERE INCUBATED AT REMARK 280 18 DEGREES., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.46400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 18.34400 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 18.34400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 105.69600 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 18.34400 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 18.34400 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 35.23200 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 18.34400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 18.34400 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 105.69600 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 18.34400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 18.34400 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 35.23200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.46400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 10 CG CD OE1 OE2 REMARK 470 LYS A 47 NZ REMARK 470 LYS A 58 CD CE NZ REMARK 470 ARG A 77 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 124 NE CZ NH1 NH2 REMARK 470 ASN A 126 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ2 LYS A 125 O13 QO6 A 201 1.53 REMARK 500 O HOH A 369 O HOH A 423 2.04 REMARK 500 O HOH A 372 O HOH A 382 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 351 O HOH A 436 1545 1.88 REMARK 500 O HOH A 411 O HOH A 411 7645 1.96 REMARK 500 OD2 ASP A 33 OG1 THR A 78 4545 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 99 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 435 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A 436 DISTANCE = 6.22 ANGSTROMS REMARK 525 HOH A 437 DISTANCE = 6.55 ANGSTROMS REMARK 525 HOH A 438 DISTANCE = 8.58 ANGSTROMS DBREF 8A4Y A 10 126 UNP P0DTD1 R1AB_SARS2 10 126 SEQADV 8A4Y MET A 9 UNP P0DTD1 INITIATING METHIONINE SEQRES 1 A 118 MET GLU LYS THR HIS VAL GLN LEU SER LEU PRO VAL LEU SEQRES 2 A 118 GLN VAL ARG ASP VAL LEU VAL ARG GLY PHE GLY ASP SER SEQRES 3 A 118 VAL GLU GLU VAL LEU SER GLU ALA ARG GLN HIS LEU LYS SEQRES 4 A 118 ASP GLY THR CYS GLY LEU VAL GLU VAL GLU LYS GLY VAL SEQRES 5 A 118 LEU PRO GLN LEU GLU GLN PRO TYR VAL PHE ILE LYS ARG SEQRES 6 A 118 SER ASP ALA ARG THR ALA PRO HIS GLY HIS VAL MET VAL SEQRES 7 A 118 GLU LEU VAL ALA GLU LEU GLU GLY ILE GLN TYR GLY ARG SEQRES 8 A 118 SER GLY GLU THR LEU GLY VAL LEU VAL PRO HIS VAL GLY SEQRES 9 A 118 GLU ILE PRO VAL ALA TYR ARG LYS VAL LEU LEU ARG LYS SEQRES 10 A 118 ASN HET QO6 A 201 26 HETNAM QO6 N-(2,3-DIHYDRO-1H-INDEN-5-YL)ACETAMIDE HETSYN QO6 ~{N}-(2,3-DIHYDRO-1~{H}-INDEN-5-YL)ETHANAMIDE FORMUL 2 QO6 C11 H13 N O FORMUL 3 HOH *138(H2 O) HELIX 1 AA1 GLN A 22 VAL A 26 5 5 HELIX 2 AA2 SER A 34 GLY A 49 1 16 HELIX 3 AA3 VAL A 60 LEU A 64 5 5 HELIX 4 AA4 ALA A 79 HIS A 83 5 5 SHEET 1 AA1 8 ILE A 95 TYR A 97 0 SHEET 2 AA1 8 VAL A 84 LEU A 92 -1 N ALA A 90 O TYR A 97 SHEET 3 AA1 8 ALA A 117 ARG A 124 1 O LEU A 122 N VAL A 84 SHEET 4 AA1 8 HIS A 13 VAL A 20 -1 N VAL A 20 O ALA A 117 SHEET 5 AA1 8 CYS A 51 VAL A 54 1 O LEU A 53 N PRO A 19 SHEET 6 AA1 8 THR A 103 PRO A 109 -1 O VAL A 108 N GLY A 52 SHEET 7 AA1 8 TYR A 68 ARG A 73 -1 N VAL A 69 O LEU A 107 SHEET 8 AA1 8 VAL A 84 LEU A 92 -1 O VAL A 89 N PHE A 70 CISPEP 1 GLN A 66 PRO A 67 0 -9.34 CRYST1 36.688 36.688 140.928 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027257 0.000000 0.000000 0.00000 SCALE2 0.000000 0.027257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007096 0.00000